Consenso Delphi intersocietario argentino sobre diagnóstico, tratamiento y seguimiento del carcinoma diferenciado de tiroides: FASEN | SAEM | AACCYC | AABYMN | AAOC
EndoAr · 26.06.2026 · 2 (2) · 92-130
DOI: 10.65640/4c6m9685 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift EndoAr, online erschienen am 26.06.2026. Verfasst von Fabián Pitoia und 32 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Differentiated thyroid carcinoma (DTC) has shown a sustained worldwide increase in incidence, with low disease-specific mortality, which has driven an increasingly individualized approach. The aim of this study was to develop a national intersocietal Delphi consensus to formulate clinical recommendations on the evaluation, treatment, and follow-up of DTC, tailored to the local context. Materials and methods: we conducted a consensus study using a modified Delphi methodology. An interdisciplinary expert panel appointed by FASEN, SAEM, AACCyC, AABYMN, and AAOC assessed clinical statements organized into thematic domains spanning the entire DTC care continuum. Each statement was rated on a 9-point Likert scale. A priori consensus criteria were defined based on the median, interquartile range (IQR), and the proportion of ratings in the 7-9 range. Items not reaching consensus were re-evaluated in subsequent rounds. Results: a total of 196 statements were evaluated across 13 thematic domains. In the final analysis, overall consensus was achieved in 99.5% of the items. The highest levels of agreement were observed in initial evaluation, standardization of the pathology report, risk stratification (initial and dynamic), indications and preparation for radioiodine therapy, and response-guided follow-up. The item with the lowest level of agreement concerned the use of low-activity diagnostic ¹³¹I scanning prior to therapy in intermediate- and high-risk patients, reflecting the need for clinical individualization and adaptation to the local context. Conclusions: this intersocietal consensus provides structured, context-specific clinical recommendations for comprehensive DTC management. It also offers a framework to support clinical decision-making in heterogeneous scenarios and delineates priorities for research and future updates.
Zitieren
APA
Pitoia, F., Abelleira, E., Galíndez, M. M., Poenitz, F., Melado, G. E., Falco, A., Califano, I., Sáez, M. E., Zund, S., Mollerach, A. M., Carrera, J. M., Jerkovich, F., Barria, G. E., Notti, A., Castro, R. B., Geres, A. E., Guerra, J. L., Gonza, M. N., Figari, M. F., …, & Stieben, L. A. R. (2026). Consenso Delphi intersocietario argentino sobre diagnóstico, tratamiento y seguimiento del carcinoma diferenciado de tiroides: FASEN | SAEM | AACCYC | AABYMN | AAOC. EndoAr, 2(2), 92-130. https://doi.org/10.65640/4c6m9685
Vancouver
Pitoia F, Abelleira E, Galíndez MM, Poenitz F, Melado GE, Falco A, et al. Consenso Delphi intersocietario argentino sobre diagnóstico, tratamiento y seguimiento del carcinoma diferenciado de tiroides: FASEN | SAEM | AACCYC | AABYMN | AAOC. EndoAr. 2026;2(2):92-130. doi:10.65640/4c6m9685
BibTeX
@article{Pitoia2026,
author = {Pitoia, Fabián and Abelleira, Erika and Galíndez, María Macarena and Poenitz, Fernando and Melado, Graciela Eva and Falco, Agustín and Califano, Inés and Sáez, María Elisa and Zund, Santiago and Mollerach, Ana María and Carrera, Juan Manuel and Jerkovich, Fernando and Barria, Graciela Edith and Notti, Alberto and Castro, Ricardo Belisario and Geres, Alejandra Elba and Guerra, Jorgelina Luz and Gonza, María Natalia and Figari, Marcelo Fernando and Gelman, Liliana Mabel and Picasso, María Fabiana Russo and Damilano, Roxana Analía and Ruggieri, Marcelo Alejandro and Schiró, Laura María and Ase, Eugenia María and Smulever, Anabella and Torres, Eduardo Alejandro and Sklate, Rosana Teresita and Brunas, Oscar Marcelo and Cavallo, Andrea Camila and Bielski, Laila Yael and Damiano, Gabriel and Stieben, Luis Agustín Ramírez},
title = {Consenso Delphi intersocietario argentino sobre diagnóstico, tratamiento y seguimiento del carcinoma diferenciado de tiroides: FASEN | SAEM | AACCYC | AABYMN | AAOC},
journal = {EndoAr},
year = {2026},
volume = {2},
number = {2},
pages = {92--130},
doi = {10.65640/4c6m9685}
}
EUVIMED